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In the present study, hexane, ethyl acetate and methanol fraction of  Amomum nilgiricum leaf
was evaluated  for  antidiabetic  efficacy,  scavenging activities,  followed by estimation of  total
phenol,  total  flavonoids.  In  the  present  study,  a  significant  amounts  of  total  phenolics
(79.92±1.58 mg/g) and flavonoids (21.74± 0.89 mg/g) were showed from Ethyl acetae fraction.
H2O2 scavenging  activity  (97.62±2.89%)  with  IC50 value  of  78.57  µg/ml  concentrations.  Ethyl
acetate  fraction  exhibited  maximum  inhibitory  activity  of  glucose  movement  into  outer
solution across dialysis membrane at 250 µg/ml as compared to the control. The ethyl acetate
fraction revealed maximum insulin secretory activity (130.5±3.66%) in RIN-m5F cells. Methanol
fraction  recorded  maximum  glucose  uptake  percent  in  yeast  cells  (67.08±1.68%)  when
compared  to  standard  metronidazole  (68.06±0.73%).  This  study  scientifically  validates  the
antidiabetic activity of  A. nilgiricum. Hence, in view of its comparative hypoglycemic strength,
it can work as a valuable healing agent in treating diabetes.
Introduction
Diabetes  is  an  utmost  widespread and  prolonged
endocrine  disease  disturbing  the  metabolism  of
carbohydrate, lipid and protein (1). The abnormal
metabolic  disarray  characterized  by
hyperglycemia occurs while either the pancreatic
cells  do  not  secrete  adequate  insulin,  or  while
body  cells  are  unable  to  successfully  use  the
insulin  formed  (2).  The  long-term  problems  of
diabetes  contain  heart  disease,  stroke,
atherosclerosis leading to dysfunction and organs
failure. Based on 2015 World Health Organization
(WHO) reports, globally, about 422 million people
(aged  20–79)  were  living  with  diabetes,  and  by
2040  it  may  rise  to  650  million  (3,  4).  In  India,
diabetes  population  is  estimated  to  be  61.3
million,  and  it  may  increase  up  to  101.2  million
until  2030 (5).  This  large number which accounts
for nearly 20% of the global patients,  has deemed
India  as  the  world’s  capital  of  diabetes  (6,  7).
During  the  hyperglycemic  condition,  there  is  a
constant  formation  of  reactive  oxygen  species
(ROS).  It  is  evident  that  diabetes  influences
modifications  in  the  actions  of  the  antioxidant
enzymes  in  numerous  tissues.  This  oxidative
stress  further  involved  in  the  improvement  and
advancement  of  diabetes  related  problems.
Antioxidants  show  significant  functions  in  free
radicals  scavenge  with  defending  cells  by
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oxidative  pressure  (8–10).  The  treatment  of
diabetes  remains  a  global  health  challenge.
Early-stage  diabetes  treatment  includes  the
postprandial  reduction  hyperglycemia  by
delaying  the  breakdown  of  hydrocarbons  into
absorbable monosaccharides over the prevention
of  hydrocarbons  degrading  enzymes  viz.,  α-
amylase  and  α-glucosidase  present  in  the
gastrointestinal  strip. Consequently,  declining
the  pace  of  glucose  absorption  also,  in  turn,
dampening  the  postprandial  glucose  increase
(11). 
At present, there are a variety of therapeutic
approaches comprising hypoglycemic agents viz.,
α-glucosidase  inhibitors  (miglitol,  voglibose  and
acarbose),  insulin  secretagogues  (sulfonylureas
and  glinides),  insulin  sensitizers
(thiazolidinediones  –  metformin  and
pioglitazone).  These  drugs  have  limitation  in
their  usage  such  as  generating  hypoglycemia  at
more  doses,  liver  cell  injury,  lactic  acidosis,
headache  and  diarrhoea  (12–16).  Control  of
diabetes mellitus (DM) without any side effects is
still  a  challenge  to  the  remedial  system.
Medicinal  plant/plant  extracts  are  effectively
used  since  ancient  time  for  management  of
diabetes  as  they  are  reported  to  be  more
effective, less side effects and relatively low cost.
According  to  WHO  (2002),  medicinal  plant/plant
extracts are being used to treat diabetes in about
90%  of  the  population  in  developing  countries.
Therefore, identifying and evaluating such plants
have  become more important  (17–20).  The  WHO
has  registered  21,000  medicinal  plants  used
around  the  world  and  150  plant  species  used
commercially.  Among  these  2500  species  are
reported from the Indian subcontinent. There are
about  800  species  reported  to  have  antidiabetic
activity  (21).  Most  of  the  plants  are  known  to
possess antioxidant with antidiabetic activities. It
has  been  observed  that  the  reduction  of  lipid
peroxidation  plus  improved  antioxidant  could
decrease diabetes complaints (22).
Amomum nilgiricum V. P. Thomas & M. Sabu
is  a  recently  described  species  of  the  family
Zingiberaceae  (23),  from  the  Western  Ghats,
Kerala,  India.  The  family  comprises  with  53
genera with more than 1200 species, numerous of
them  are  generally  known  for  therapeutic  uses
(24). A. nilgiricum is robust, clump forming habit,
stout and non-stoloniferous rhizomes,  lanceolate
to  elliptic-lanceolate,  32−41  ×  6.5−8  cm.  Lamina,
2−8 mm long,  petiole,  tomentose beneath leaves,
4.5−9 cm long and persistent  ligule,  corolla  tube
is longer than labellum,  labellum is not trilobed,
uniformly  yellow  and  emarginate  anther  crest
and reduced staminodes (23). 
During  the  current  study,  the  antidiabetic
and  antioxidant  activity  of  different  extracts
from  A.  nilgiricum leaves  was  performed.  To
assess  the  efficacy  of  A.  nilgiricum extract  as
antidiabetic  agents,  we  examined  the  influence
on  the  ability  of  glucose  transport  across  yeast




Folin  Ciocalteu  reagent,  NaNO2,   hydrogen
peroxide,  gallic  acid,  NaCl,  Na2CO3,  glucose,  KCl,
NaCl, MgCl2, NaH2PO4, CaCl2.
Plant material collection and extraction
Amomum nilgiricum was obtained from the region
of  Western Ghats,  Kerala,  India  at  an  altitude  of
1150  m  mean  sea  level  (MSL).  The  leaves  of  the
plants  were  rinsed  in  water  and  washed  in
sterilized  distilled  water  and  shade  dried.  The
dehydrated leaf samples were powdered and used
for  the  extraction process.  Powdered leaves  (100
g)  were  extracted  using  a  water-ethanol  mixture
(ratio of 80:10) on a magnetic stirrer for 24 hr. The
leaf  extract was filtered and dried at 40 ºC using
vacuum evaporator.  The  dried  crude  leaf  extract
was  dissolved  in  250  ml  of  sterilized  distilled
water for further fractionation. The extracts were
separated  with  methanol,  hexane  and  ethyl
acetate  and  these  fractions  were  dried  using
vacuum evaporator and used for further studies. 
Estimation of total phenols
The  whole  content  of  phenol  was  estimated  by
Folin  Ciocalteu  (FC)  as  per  the  standard  method
(25). In brief, 100 μl of fractions was made up to 2
ml  with  sterile  distilled  water  and  500  µl  of  FC
reagent was added and incubated for 3 min. After
incubation,  2  ml  of  Na2CO3  was  added  and  the
sample  was incubated  in  warm water  for  1  min.
The  content  was  allowed  to  cool  and  the
absorbance  was  recorded  at  765  nm  using  a
spectrophotometer (Elico-Japan).  The total  phenol
content  was  stated  as  mg  gallic  acid  equivalents
(GAE) g-1.
Determination of total flavonoids
The  total  flavonoids  content  was  assessed as  per
the standard procedure (26). The reaction mixture
comprises  100  μl  of  different  fractions  and  the
solution  was  made  up  to  2  ml  with  the  distilled
water  and  incubated  at  room  temperature  for  3
min. Further, 300 µl of AlCl3 and 300 µl of NaNO2
was added to the above mixture and the mixture
was  allowed  to  stand  for  6  min.  Then,  1  M  of
NaOH solution  (2  ml)  was  added  and  the  final
final  volume  of  the  reaction  mixture  was
prepared to 10 ml with sterile water. The mixture
was  allowed  to  stand  for  15  min  and  the
absorbance  was  measured  at  510  nm.  and
flavonoid  concentration  expressed  as  mg
quercetin  equivalent  g -1 extract.  The  total
flavonoid  content  was  calculated  from  a
calibration curve and the result was expressed as
mg rutin equivalent per g dry weight.
Estimation  of  antioxidant  activity  by  in  vitro
methods
Hydrogen peroxide scavenging capacity
The hydrogen peroxide (H2O2) scavenging activity
of  the  fractions  were  performed  as  per  the
standard  procedure  (27).  Hydrogen  peroxide  (40
mM)  in  phosphate  buffer  was  prepared  and
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fractions  at  different  concentrations  (0.78–100
µg/ml)  were added with  0.6  ml of  distilled  water
prepared  to  3  ml  (pH  7.4).  After  30  min,
absorbance  was  recorded  at  230  nm  against  a
blank  solution.  Gallic  acid  was  used  as  as  a
positive  control.  The  %  H2O2  scavenging  activity
was evaluated by the following formula:
Estimation of antidiabetic activity
Glucose diffusion measurement: 
The  Glucose  diffusion  method  was  performed
according  to  the  standard method  (28).  The
experiment was performed in a dialysis bag (7.6 cm x
15  mm,  dialysis  tubing  cellulose  membrane,  Sigma
Aldrich),  6  ml  of  fractions  was  added  into  dialysis
bag,  along  with  2  ml  0.15  M  Sodium  chloride
containing  0.22  mM  glucose.  The  closed  dialysis
tubing positioned in a centrifuge tube comprising 100
ml of 0.15 M NaCl in an orbital shaker and incubated
for 3 hr at 37 °C. Amount of glucose inside the dialysis
tube was recorded and control contains 2 ml of 0.15
M NaCl having 0.22 mM glucose with 1 ml distilled
water. The glucose movement into the outer solution
was  examined  each  half  an  hour  using  glucose
oxidase  peroxidase  diagnostic  kit  (Sigma-Aldrich).
The glucose concentration was verified every 30 min
for  3  hr.  The  glucose  diffusion  retardation  index
(GDRI)  was  calculated  using  the  following  formula:
GDRI  =  (100  −  glucose  content  (µg/ml)  in  external
solution in the presence of sample /glucose content
(µg/ml) in external solution in the absence of sample)
×100.
Glucose uptake in yeast cells
Glucose uptake in yeast cell was evaluated as per the
standard  procedure  (29).  The  baker’s  yeast
(Saccharomyces  cerevisiae)  was  subjected  to
repetitive centrifugation (Thermo Fischer) (3000 rpm,
for  5  min)  in  distilled  water  until  the  supernatant
fluids were was clear and a 10% (v/v) uspension was
prepared in distilled water. Leaf extract fractions of
50–250  μg/ml  +  1  ml  of  5,  15  and  25  mM  glucose
solution added and incubated at 37 °C for 10 min. The
reaction  was  initiated  by  addition  of  100  μl  yeast
suspension  to  the  combination  of  glucose  and
fractions was mixed and incubated at 37 °C for 1 hr.
It  is  centrifuged  at  (2500  rpm for  5  min),  and  the
quantity of glucose in the sample is assessed by using
a  spectrophotometer  at  520  nm.  The  %  of  glucose
uptake was determined by: 
Glucose uptake (%) = Abs control −Abs fractions / Abs
control × 100
Insulin secretion assay
The amount of insulin released by RIN-m5F cells was
estimated  (30).  Cells  RIN-5F  cell  line  was  obtained
from National  Centre  for  Cell  Science,  Pune,  India.
The RIN-m5F cells (105 cells/ml) was isolated in fresh
RPMI-1640  growth  medium  (supplementary  with  1
mM sodium pyruvate, 10% FBS, 10 mM HEPES) 90%;
fetal  bovine  serum  10%,  antibiotics  (100  µg/ml
streptomycin,  100 IU/ml penicillin  G,  and 2.5  µg/ml
amphotericin  B)  added  0.2  ml  into  96-well  plates.
Plate kept in a 5% CO2 incubator at 37 °C for 48 hr,
after incubation, the medium was removed and cells
incubated in glucose-free Krebs-Ringer (KRB) buffer
(3.6  mM  KCl,  1.5  mM  CaCl2, 135  mM  NaCl,  5  mM
NaHCO3, 0.5 mM MgCl2 0.5 mM NaH2PO4) added with
1 mg/ml BSA and 10 mM HEPES incubated for 2 hr.
The  growth  medium  removed  and  substituted  by
100μl  of  glucose-free  KRB  comprising  different
concentrations  (50–250  μg/ml)  fractions.
Glibenclamide  (1,  10,  100  μM)  acts  as  a  positive
control. After one hr of incubation, aliquots of 25 µl
of media was collected from every well and assessed
for the  amount of  insulin.  The insulin  content  was
estimated by DRG diagnostic insulin ELISA kit by: %
of  insulin  secreted  = [(Abs  treated  cells/Abs  control
cells)  × 100] -  100.  The quantity  of  insulin  secreted
was expressed as µU/ml. 
Result
Total phenolic and flavonoid contents
The  total  phenolic  and  flavonoid  contents  from
ethyl  acetate,  hexane,  methanol,  and  aqueous
fractions of A. nilgiricum leaves were shown in Fig.
1. The  ethyl  acetate  fraction  showed  maximum
phenolic content (79.92±1.58 mg/g) while methanol,
hexane  and  aqueous  fractions  showed  47.67±0.66
mg/g,  37.46±1.12  mg/g and  65.51±1.83 mg/g
respectively.  The  ethyl  acetate  fraction  showed
maximum  flavonoid content  (21.74±0.89  mg/g)
while  methanol,  hexane  and  aqueous  fractions
showed  19.76  mg/g,  18.64  mg/g and  9.51  mg/g
respectively.
H2O2 scavenging activity
The  scavenging  capacity  of  fractions  on  hydrogen
peroxide  was  shown  in  Fig.  2.  The  A.  nilgiricum
leaves fractions were capable of scavenging H2O2 in a
dose  dependent  manner.  The ethyl  acetate  fraction
showed  maximum  H2O2 scavenging  activity  of
97.62±2.89%  followed  by  methanol  (90±1.33 %),
hexane  (86.43±1.56%)  and  water  fraction  was
revealed lowest H2O2 scavenging activity of 85±1.89%.
The IC50 values as follows: ethyl acetate – 78.57 µg/ml,
methanol  –  83.62  µg/ml,  hexane  –  92.38  µg/ml  and
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Fig.  1.  Determination  of  total  phenolic  and  flavonoid  from
different fractions of A. nilgiricum leaves.
aqueous fraction – 115.57 µg/ml. The standard, gallic
acid, showed 62.33 μg/ml. 
In vitro glucose diffusion
The  effects  of  different  fractions  tested  upon
glucose  diffusion  in-vitro are  shown  in  Fig.  3a.
Glucose diffusion assay was conducted to examine
the influence of different fractions of leaf extracts
with  respect  to  its  glucose  retardation  activity
across  the  dialysis  tube.  The  glucose  diffusion  at
the  different  times  assayed  was  significantly
different  between  the  fractions.  The  amount  of
glucose diffusion was recorded to increase from 30
to  180  min.  Ethyl  acetate  fraction  showed
inhibitory  effects  on  transmission  of  glucose  into
the outside solution across the dialysis  membrane
and  aqueous  fraction  was  showed  minimum
inhibition to the diffusion of glucose as related to
the  control.  For  all  fractions,  the  rate  of  glucose
transfer  into  external  solution  was  lesser  than
control. The  fractions  were  exhibited  GDRI
between  19%  and  26%.  GDRI  (%)  reduced  with
decreasing concentration of the fractions  (Fig.  3b).
The aqueous fraction was revealed to show better
GDRI at 250 µg/ml concentration. 
Glucose uptake in yeast cells
The effect of fractions on glucose uptake across yeast
cell  membrane  was  determined  in-vitro system
containing yeast cells  suspended in a 5,  15,  25 mM
glucose  solution  at  different  concentrations  (Fig.
4).The result of metronidazole on glucose uptake by
the yeast cells at 25 mM glucose was a little higher as
compared to the fractions. All the fractions increased
yeast  cells  glucose  uptake.  Among  the  fractions,
methanolic  fraction was showed maximum glucose
uptake of 67.08±1.68% which was nearly close to the
standard  metronidazole,  i.e.  68.06±0.49%,
71.06±2.62%, 71.06±2.62% concentrations at 5 mM, 15
mM, 25 mM respectively (Table 1). 
Insulin secretion assay
The  effect  of  fractions  on  insulin  secretion  was
evaluated  on  RIN-m5F  cell  lines.  The  fractions
significantly stimulated the insulin secretion in RIN-
m5F pancreatic cells in comparison to Glibenclamide
(Fig.  5). The  ethyl  acetate  fraction  was  revealed
maximum insulin secretory effect on RIN-m5F cells
when  when  compared  to  other  fractions.  A  dose-
dependent  increase  in  insulin  secretion  was
significantly improved from different concentrations
of  62.5  μg/ml  to  500  μg/ml  as  compared  to
Glibenclamide (1, 10, 100 μM). 
Discussion
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Table 1. Percentage of glucose uptake in yeast cells treated with A. 

















50 44.87±0.98 38.92±0.66 25.78±0.57
100 49.78±1.28 44.97±0.57 28.46±0.68
150 54.95±1.16 50.65±089 32.66±0.89
200 65.98±1.33 62.891.34 35.12±0.76
250 77.66±1.125 71.54±1.66 36.34±0.98
Ethyl 
acetate 
50 35.74±0.98 31.32±0.57 18.67±0.57
100 37.89±1.37 32.87±0.66 21.43±0.56
150 38.65±1.56 39.66±0.78 25.54±0.43
200 51.42±1.89 48.32±1.12 29.76±0.89
250 69.06±2.13 61.54±1.56 34.67±0.66
Methanol
50 36.76±1.46 33.23±0.66 21.66±0.6
100 39.99±1.63 35.76±0.57 25.87±0.89
150 47.75±1.83 42.18±1.32 28.45±0.57
200 59.42±2.26 52.65±1.45 33.23±0.98
250 71.06±2.62 65.87±2.12 36.56±0.57
Hexane 
50 28.64±0.66 21.78±0.89 19.34±0.66
100 32.97±1.32 28.54±0.66 21.34±0.56
150 36.85±1.11 32.76±0.89 24.91±0.89
200 45.44±1.34 38.33±0.87 29.45±0.54
250 61.43±1.89 59.43±1.46 31.66±0.48
Aqueous 
50 29.51±0.98 21.43±0.78 17.67±0.33
100 35.23±1.21 27.45±0.66 19.32±0.78
150 37.62±1.16 31.89±0.57 21.43±0.66
200 49.77±1.57 40.65±1.33 26.87±0.98
250 63.55±1.98 48.76±1.63 29.78±0.73
Results  are  expressed  as  mean ± SE  (n=3)  of  three independent
experiments.
Fig.  2. H2O2 scavenging  activity  of  different  fractions  of  A.
nilgiricum leaves.
Fig. 3. Effect of different fractions of  A. nilgiricum leaves on the
diffusion of glucose across the dialysis membrane.  a) Diffusion of
glucose  across  the  dialysis  tube  at  250  µg/ml  at  different  time
intervals.  b) Glucose diffusion retardation index after 3 hr at 250
µg/ml concentration.
Diabetes  mellitus is  one  of  the  growing  metabolic
disorder worldwide. The defectiveness in the energy
regulation  and  metabolism  of  the  body  because  of
insulin  resistance  otherwise  scarcity  to  elevated
blood sugar points leading to numerous problems in
diabetes (31). Medicinal  plants  have  been used in
traditional/ayurvedic  usage  to  treat  Diabetes
mellitus,  especially  in  developing  countries (32).
The phytocomponents of the plant extracts which
show hypoglycemic effect may work separately or
synergistically  (33,  34).  Further,  the  secondary
plant  metabolites  associated  with  antioxidants
prevent the damage of pancreatic beta cell due to
oxidative stress. 
The  α-amylase  and  α-glucosidase  enzymes
hydrolyze  α-1,4-glucosidic  linkages  to  liberate  α-
glucose.  Inhibition of these enzymes expressively
reduces  the  postprandial  acceleration  in  blood
glucose (11).  Earlier  studies  suggested that  plant-
derived  phenolics  have  significantly  inhibited  α-
amylase  and  α-glucosidase  activities  (35–37).  The
side  effect  of  diabetes  drugs  is  mainly  due  to
extreme  inhibition  of  pancreatic  α-amylase
resultant  in  the  irregular  bacterial  fermentation
of unused sugars in the colon (38). 
The  plant  fractions  dose-dependently
increased  the  glucose  uptake  in  yeast  cells.  The
transport  of  glucose  across  the  yeast  cell
membrane  is  an  effective  model  to  evaluate  the
hypoglycemic  effect  (39).  Glucose  uptake  is
mediated by stereospecific membrane carriers (40).
The  methanol  fraction  of  A.  nilgiricum leaves
exhibited  the  maximum  glucose  transport  across
yeast  cells  followed  by  ethyl  acetate,  hexane  and
aqueous fractions.
A.  nilgiricum leaves  fractions  inhibited  the
amount of glucose diffusion across the membrane;
hence,  they  can  act  as  a  promising  inhibitor  in
dropping the blood glucose level by inhibiting the
movement  of  glucose  molecule  across  the  plasma
membrane  into  the  blood  vessel.  Ethyl  acetate
fraction  exhibited  potent  inhibitory  effects
compared  to  control.  This  indicates  that  A.
nilgiricum leaves  extract  can  significantly  inhibit
glucose  diffusion  (41).  The  glucose  GDRI  is
beneficial  in-vitro index to calculate the efficiency
of fractions  on the delay  in glucose absorption in
the  intestinal  tract  (42,  43).  The  aqueous  fraction
was recorded to have the maximum GDRI value at
250 µg/ml concentration. Similar studies have been
reported in soluble fibres, for example, oats, wheat
bran  and  psyllium  husk  were  showed  to  prevent
between 10 and 23% glucose transmission (44). 
Insulin secretory activity could be due to natural
substances  present  in  the  plant  extract,  which
stimulates  insulin  secretion  or  protects  the  intact
functional β-cells from further deterioration, so that
they remain active and continue producing insulin.
Terpenoids  and  polyphenols  from medicinal  plants
are  known  to  stimulate  the  pancreatic  beta-cell
resulting in secretion of insulin (45, 46).
Conclusion
The  result  of  the  current  research  indicates  A.
nilgiricum leaf  extracts  exhibited  antioxidant
property,  exhibited  in-vitro glucose  diffusion,
glucose  uptake  by  yeast  cells  and  stimulated
insulin-secreting effect on RIN m5F pancreatic cell
lines. Further, isolation and evaluation of bioactive
molecules could be helpful for the discovery of new
medicines to control diabetes mellitus. 
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